Veraxa Biotech is a biotechnology firm specializing in developing advanced gene-editing therapies for rare genetic disorders. Its proprietary platform uses CRISPR-based technology to precisely correct mutations at the cellular level. Patients with inherited conditions, researchers seeking targeted treatments, and healthcare providers aiming for personalized medicine benefit from its innovative solutions, which aim to improve long-term outcomes and quality of life.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends